NewslettersHepatic Cell NewsUncategorizedEZH1/2 Inhibition Augments the Anti-Tumor Effects of Sorafenib in Hepatocellular CarcinomaBy Justin.choi - November 1, 2021034Scientists investigated the relationship between the expression of EZH1/2 and the level of histone H3 Lysine 27 trimethylation in hepatocellular carcinoma.[Scientific Reports] 7992332 AAAAAAAA items 1 apa 0 default asc 1 168400 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article